Loss of insulin-mediated microvascular perfusion in skeletal muscle is associated with the development of insulin resistance

Diabetes, Obesity and Metabolism

Volumn 12, Issue 9, 2010, Pages 798-805

  St Pierre, P ^a   Genders, A J ^a   Keske, M A ^a   Richards, S M ^a   Rattigan, S ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Glucose metabolism; Insulin delivery; Insulin resistance; Microvascular disease

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMORAL ARTERY FLOW; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HEMODYNAMIC PARAMETERS; HINDLIMB; HORMONE RESPONSE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; METABOLIC PARAMETERS; MICROVASCULARIZATION; MUSCLE PERFUSION; NONHUMAN; RAT; TIME;

EID: 77955020369     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01235.x     Document Type: Article

References (41)

1. Jonk AM, Houben AJ, de Jongh RT. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) 2007, 22:252-260.
2. Defronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988, 37(6):667-687.
3. Defronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
5. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990, 85:1844-1852.
6. Rattigan S, Clark MG, Barrett EJ. Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 1997, 46(9):1381-1388.
7. Youd JM, Rattigan S, Clark MG. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNFa. Diabetes 2000, 49(11):1904-1909.
8. Wallis MG, Wheatley CM, Rattigan S. Insulin-mediated hemodynamic changes are impaired in muscle of zucker obese rats. Diabetes 2002, 51(12):3492-3498.
9. Clerk LH, Vincent MA, Jahn LA. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 2006, 55(5):1436-1442.
10. Masek J, Fabry P. High-fat diet and the development of obesity in albino rats. Experientia 1959, 15:444-445.
11. Han DH, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997, 46(11):1761-1767.
12. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15(4):798-808.
13. Koshinaka K, Oshida Y, Han YQ. Insulin-nonspecific reduction in skeletal muscle glucose transport in high-fat-fed rats. Metab Clin Exp 2004, 53(7):912-917.
14. Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 1986, 29:192-198.
15. Kraegen EW, Clark PW, Jenkins AB. Development of muscle insulin resistance after liver insulin resistance in high- fat-fed rats. Diabetes 1991, 40:1397-1403.
16. Kim F, Pham M, Maloney E. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28(11):1982-1988.
17. Kraegen EW, James DE, Jenkins AB, Chisholm DJ. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 1985, 248:E353-E362.
18. Burnol AF, Leturque A, Girard PJ. A method for quantifying insulin sensitivity in vivo in the anesthetized rat: the euglycemic insulin clamp technique coupled with isotopic measurement of glucose turnover. Reprod Nutr Dev 1983, 23:429-435.
19. Rattigan S, Wallis MG, Youd JM, Clark MG. Exercise training improves insulin-mediated capillary recruitment in association with glucose uptake in rat hindlimb. Diabetes 2001, 50(12):2659-2665.
20. Zhang L, Vincent MA, Richards SM. Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 2004, 53(2):447-453.
21. Clark MG. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 2008, 295(4):E732-E750.
22. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32(Suppl. 2)):S157-S163.
23. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002, 32(Suppl. 3):14-23.
24. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006, 45(1):42-72.
25. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106(2):171-176.
26. Machann J, Haring H, Schick F, Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metabol 2004, 6(4):239-248.
27. Kim F, Tysseling KA, Rice J. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol 2005, 25(5):989-994.
28. Clerk LH, Rattigan S, Clark MG. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002, 51(4):1138-1145.
29. Steinberg HO, Paradisi G, Hook G. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000, 49(7):1231-1238.
30. Abel ED, Peroni O, Kim JK. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001, 409(6821):729-733.
31. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
32. Valerio A, Cardile A, Cozzi V. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 2006, 116(10):2791-2798.
33. Duplain H, Burcelin R, Sartori C. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001, 104(3):342-345.
34. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000, 49(5):684-687.
35. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003, 285(1):E123-E129.
36. Chatterjee TK, Stoll LL, Denning GM. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009, 104(4):541-549.
37. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009, 335(1):165-189.
38. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005, 365(9473):1817-1820.
39. Erdei N, Toth A, Pasztor ET. High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am JPhysiol Heart and Circ Physiol 2006, 291(5):H2107-H2115.
40. Fueger PT, Lee-Young RS, Shearer J. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Diabetes 2007, 56(10):2476-2484.
41. Zou B, Suwa M, Nakano H. Adaptation of skeletal muscle characteristics to a high-fat diet in rats with different intra-abdominal-obesity susceptibilities. J Nutr Sci Vitaminol 2003, 49(4):241-246.